Financials

  • Market Capitalization 4.29 B
  • Employee 137
  • Founded 2017
  • CEO N/A
  • Website www.tangotx.com
  • Headquarter Delaware, United States
  • FIGI BBG00WFDDRS0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.18
Rapporto prezzo/fatturato
16.5

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1426
VKTX
Viking Therapeutics, Inc. - Common Stock
37.97 USD-0.39%-9.29%+28.71%+21.50%4.41 B USD
1436
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.49 USD-0.04%-2.52%+19.50%+15.44%4.36 B USD
1450
EWTX
Edgewise Therapeutics, Inc. - Common Stock
39.73 USD-3.73%-7.54%+11.26%+160.87%4.27 B USD
1529
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
33.29 USD+0.03%-9.19%+8.97%-8.22%3.89 B USD

Notizie